相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The healthcare field as a marketplace: general practitioners, pharmaceutical companies, and profit-led prescribing in Pakistan
Muhammad Naveed Noor et al.
HEALTH SOCIOLOGY REVIEW (2023)
The Role of Social Norms on Direct-to-Physician Pharmaceutical Marketing Payment Acceptance
Pui Ying Tong et al.
JOURNAL OF PUBLIC POLICY & MARKETING (2022)
Ethics in Dealing with Pharma Industry
Om Prakash Singh et al.
INDIAN JOURNAL OF PSYCHIATRY (2022)
Antibiotic use and resistance in Belgium: the impact of two decades of multi-faceted campaigning
R. Bruyndonckx et al.
ACTA CLINICA BELGICA (2021)
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? A Systematic Review
Aaron P. Mitchell et al.
ANNALS OF INTERNAL MEDICINE (2021)
Perceptions of and barriers to ethical promotion of pharmaceuticals in Pakistan: perspectives of medical representatives and doctors
Rehan Gul et al.
BMC MEDICAL ETHICS (2021)
Improving antibiotic use through behaviour change: a systematic review of interventions evaluated in low- and middle-income countries
Carla Cuevas et al.
HEALTH POLICY AND PLANNING (2021)
Real time surveillance of COVID-19 space and time clusters during the summer 2020 in Spain
Nicolas Rosillo et al.
BMC PUBLIC HEALTH (2021)
Conflicts of interest: an invisible force shaping health systems and policies
Afifah Rahman-Shepherd et al.
Lancet Global Health (2021)
Factors influencing the inappropriate use of antibiotics in the Rupandehi district of Nepal
Anant Nepal et al.
INTERNATIONAL JOURNAL OF HEALTH PLANNING AND MANAGEMENT (2021)
Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018
Olivier J. Wouters
JAMA INTERNAL MEDICINE (2020)
Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus
Chantal M. Morel et al.
JOURNAL OF ANTIBIOTICS (2020)
What are the barriers to implementing national antimicrobial resistance action plans? A novel mixed-methods policy analysis in Pakistan
Mishal S. Khan et al.
HEALTH POLICY AND PLANNING (2020)
Antimicrobial resistance in nephrology
Tina Z. Wang et al.
NATURE REVIEWS NEPHROLOGY (2019)
Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
Yurie Kobashi et al.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2019)
The Ethics of Pharma-Physician Relations in Pakistan: When in Rome
Marisa de Andrade et al.
ETHICS & BEHAVIOR (2019)
Individual and Institutional Corruption in European and US Healthcare: Overview and Link of Various Corruption Typologies
Margit Sommersguter-Reichmann et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2018)
A Bitter Pill? Institutional Corruption and the Challenge of Antibribery Compliance in the Pharmaceutical Sector
Elizabeth David-Barrett et al.
JOURNAL OF MANAGEMENT INQUIRY (2017)
Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile
Ana Correa et al.
BMJ OPEN (2016)
Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs
Donald W. Light et al.
JOURNAL OF LAW MEDICINE & ETHICS (2013)
Institutional Corruption and the Pharmaceutical Policy INTRODUCTION
Marc A. Rodwin
JOURNAL OF LAW MEDICINE & ETHICS (2013)
Can We Close The Income And Wealth Gap Between Specialists And Primary Care Physicians?
Bryan T. Vaughn et al.
HEALTH AFFAIRS (2010)
Defining quality of care
SM Campbell et al.
SOCIAL SCIENCE & MEDICINE (2000)